Tomasdottir H, Henriksson B A, Bengtson J P, Bengtsson A, Stenqvist O, Persson H
Department of Anaesthesiology and Intensive Care, Sahlgren Hospital, Göteborg, Sweden.
Transplantation. 1993 Apr;55(4):799-802. doi: 10.1097/00007890-199304000-00022.
Twelve patients with end-stage liver disease undergoing liver transplantation were studied regarding complement activation and formation of anaphylatoxins (C3a and C5a) and terminal C5b-9 complement complexes (TCC) after reperfusion of the grafted liver. Blood samples for complement variables (C1INH, C3, C4, C5, C3a, C5a, and TCC) were drawn preoperatively, before the anhepatic phase, 1 min before, and 2, 15, and 60 min after the start of reperfusion of the grafted liver. Activation of complement was observed during the operation. The C1INH, C3, C4, and C5 plasma concentrations decreased during the entire operation while the anaphylatoxin C3a and the terminal C5b-9 complement complex increased after the reperfusion of the grafted liver. Activation of complement with the formation of biologically active substances like anaphylatoxins and terminal C5b-9 complement complexes may be one explanation for circulatory complications often seen in patients undergoing orthotopic liver transplantation.
对12例接受肝移植的终末期肝病患者进行了研究,观察移植肝再灌注后补体激活及过敏毒素(C3a和C5a)和终末C5b-9补体复合物(TCC)的形成情况。在术前、无肝期前、移植肝再灌注开始前1分钟以及再灌注开始后2分钟、15分钟和60分钟采集血样检测补体相关指标(C1INH、C3、C4、C5、C3a、C5a和TCC)。手术过程中观察到补体激活。在整个手术过程中,C1INH、C3、C4和C5血浆浓度下降,而在移植肝再灌注后,过敏毒素C3a和终末C5b-9补体复合物增加。补体激活并形成如过敏毒素和终末C5b-9补体复合物等生物活性物质,可能是原位肝移植患者常见循环并发症的一种解释。